Invention Grant
- Patent Title: Pharmaceutical composition including mometasone furoate and azelastine hydrochloride for nasal administration
- Patent Title (中): 药物组合物，包括糠酸莫米松和盐酸氮卓斯汀用于鼻内给药
-
Application No.: US13990373Application Date: 2011-11-18
-
Publication No.: US08859531B2Publication Date: 2014-10-14
- Inventor: Sang-Yong Lee , Geun-Hyeog Lee , Byong-Sun Choi , Jong-Hyeon Ryu , Jin-Ha Park , Mi-Jin O
- Applicant: Sang-Yong Lee , Geun-Hyeog Lee , Byong-Sun Choi , Jong-Hyeon Ryu , Jin-Ha Park , Mi-Jin O
- Applicant Address: KR Gyeonggi-Do
- Assignee: Hanlim Pharmaceutical Co., Ltd
- Current Assignee: Hanlim Pharmaceutical Co., Ltd
- Current Assignee Address: KR Gyeonggi-Do
- Agency: Vorys, Sater, Seymour and Pease LLP
- Agent Mihsun Koh
- Priority: KR10-2010-0119632 20101129
- International Application: PCT/KR2011/008826 WO 20111118
- International Announcement: WO2012/074231 WO 20120607
- Main IPC: A01N45/00
- IPC: A01N45/00 ; A61K31/56 ; A61K31/58 ; A61K31/573 ; A61K31/55
Abstract:
The present invention provides a pharmaceutical composition for nasal administration comprising mometasone furoate and azelastine hydrochloride, wherein the pharmaceutical composition comprises thaumatin as an agent for reducing bitterness and irritation.
Public/Granted literature
Information query
